Mediwound Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +11.8% | -7.0% | +2.0% | -14.0% | +34.1% | -32.3% | +44.3% | -4.9% | -65.6% | -21.0% | +109.6% | – | |
| – | +19.0% | -5.7% | +5.9% | -20.3% | +34.2% | -34.8% | +35.7% | +3.8% | -64.9% | -27.5% | +139.1% | – | |
| – | -19.8% | -15.6% | -26.4% | +51.5% | +33.4% | -18.3% | +81.8% | -33.2% | -69.0% | +16.2% | +4.3% | – | |
| – | +17.9% | -18.7% | +29.1% | +33.0% | +18.3% | -3.3% | +21.0% | -0.7% | +29.2% | +15.8% | +13.8% | – | |
| – | +378.3% | -75.0% | +6.9% | +20.0% | +86.2% | -55.8% | +17.9% | +10.2% | +65.7% | -40.2% | +69.3% | – | |
| – | +17.6% | -5.9% | +13.6% | +16.8% | +21.3% | -14.6% | +18.4% | +5.1% | +9.0% | +2.6% | +18.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +0.0% | -59.7% | +115.4% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +150.0% | -80.0% | -108.3% | – | -14.3% | -72.2% | +660.0% | +39.5% | +37.7% | -123.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -159.7% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.